Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Elizabeth David to Propensity Score

This is a "connection" page, showing publications Elizabeth David has written about Propensity Score.

 
Connection Strength
 
 
 
0.724
 
  1. David EA, Daly ME, Li CS, Chiu CL, Cooke DT, Brown LM, Melnikow J, Kelly K, Canter RJ. Increasing Rates of No Treatment in Advanced-Stage Non-Small Cell Lung Cancer Patients: A?Propensity-Matched Analysis. J Thorac Oncol. 2017 03; 12(3):437-445.
    View in: PubMed
    Score: 0.483
  2. Toubat O, Atay SM, Kim AW, Ding L, Farias AJ, Ebner PJ, McFadden PM, David EA. Disparities in Guideline-Concordant Treatment for Pathologic N1 Non-Small Cell Lung Cancer. Ann Thorac Surg. 2020 05; 109(5):1512-1520.
    View in: PubMed
    Score: 0.149
  3. Woodard GA, Grau-Sepulveda M, Onaitis MW, Udelsman BV, David EA, Jacobs JP, Kosinski AS, Blasberg JD, Boffa DJ. Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation. Ann Thorac Surg. 2025 May; 119(5):1071-1081.
    View in: PubMed
    Score: 0.053
  4. Atay SM, Amini M, Ding L, David EA, Mcfadden PM, Wightman SC, Kim AW. Adjuvant Chemotherapy Improves Survival in pN-positive Clinical Stage IIIA Non-Small Cell Lung Cancer After Neoadjuvant Therapy and Resection. Ann Thorac Surg. 2021 07; 112(1):197-205.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)